| 1 |
32003602 | Bile acid treatment and FXR agonism lower postprandial lipemia in mice. | 2020 Apr 1 |
1 |
| 2 |
30409838 | Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation. | 2019 Feb |
1 |
| 3 |
30556042 | Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development. | 2018 Dec |
5 |
| 4 |
28505368 | Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway. | 2017 Aug 1 |
2 |
| 5 |
25870546 | Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior. | 2015 |
1 |
| 6 |
23051670 | Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling. | 2012 Dec 15 |
1 |
| 7 |
21464203 | Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor. | 2011 Jun |
3 |
| 8 |
16284190 | Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4. | 2006 Feb |
1 |
| 9 |
12891557 | Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. | 2003 Aug |
1 |
| 10 |
11927623 | Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. | 2002 Apr |
1 |